[Click here for information about joining the class action] On October 21, 2025, Alector issued a press release "announc[ing] results from the Phase 3 INFRONT-3 clinical trial evaluating latozinemab (AL001) in individuals with frontotemporal dementia due to a progranulin gene mutation (FTD-GRN)."Â The press release disclosed that latozinemab "did not meet the clinical co- primary endpoint of slowing FTD-GRNÂ progression," and that "the secondary and exploratory endpoints, such as fluid biomarkers and volume ...

Accessibility StatementSkip Navigation NEW YORK, Oct. 28, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in WPP plc ("WPP" or the "Company") (NYSE: WPP) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of WPP investors who were adversely affected by alleged securities fraud between February 27, 2025 and July 8, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/wpp-plc-lawsu ...

诉讼核心信息 - 针对WPP plc的证券欺诈集体诉讼已在美国纽约南区地方法院提起 [2] - 诉讼指控WPP及其部分高级管理人员违反了1934年证券交易法 [2] - 诉讼涉及在2025年2月27日至2025年7月8日期间购买或获得WPP普通股的投资者 [2] 诉讼指控内容 - 指控被告对WPP的媒体业务部门做出虚假陈述 [2] - 具体指控为虚假陈述内容涉及WPP媒体部门未准备好应对持续的宏观经济挑战，同时保持有效竞争力 [2] 法律程序相关 - 希望担任首席原告的投资者需在2025年12月8日前提交文件 [3] - 首席原告是代表其他集体成员指导诉讼的代表方 [3] - 律师事务所采用风险代理收费模式，股东无需支付任何费用 [3]

公司业务与行业 - 公司提供管理式医疗服务 主要面向低收入群体 业务包括医疗补助和医疗保险计划 [1] - 公司在医疗保健行业运营 竞争对手包括Centene Corporation和UnitedHealth Group [1] 股价表现与估值 - 摩根士丹利分析师Erin Wright设定新目标价为158美元 而股票交易价格为161美元 显示当前股价存在约-186%的轻微高估 [1] - 当前股价为16542美元 今日上涨442美元 涨幅达274% 日内交易区间在15950美元至16552美元之间 [2] - 尽管近期上涨 但公司股价近期仍出现16%的显著下跌 [2][5] - 公司52周价格区间显示 最高价为35997美元 最低价为15195美元 凸显其波动性 [2] 法律诉讼 - 公司正面临Pomerantz LLP提起的集体诉讼 指控其涉及证券欺诈和其他非法商业行为 [3] - 该法律诉讼基于《1934年证券交易法》第10(b)条和第20(a)条 针对公司及某些高级管理人员 [3] - 案件名称为Hindlemann v Molina Healthcare Inc et al 案号25-cv-9461 正在美国加州中区地方法院审理中 [4] 市场数据 - 公司市值约为897亿美元 [4][5] - 交易量为715671股 反映出尽管存在法律问题 投资者兴趣依然活跃 [4][5]

集体诉讼事件 - 波默朗茨律师事务所宣布对WPP Plc提起集体诉讼，指控公司及其部分高管可能涉及证券欺诈或其他非法商业行为 [1][2] - 在2025年7月9日WPP发布交易更新后，其美国存托凭证价格下跌6.48美元，跌幅达18.09%，收于每股29.34美元 [4][5] 公司经营表现 - WPP在2025年上半年交易更新中表示，第二季度业绩出现恶化，原因包括持续的宏观不确定性抑制客户支出，以及净新业务增长弱于预期 [4] - 公司业绩部分受到WPP Media持续重组带来的业务干扰影响 [4]

Accessibility StatementSkip Navigation NEW YORK, Oct. 24, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in RCI Hospitality Holdings, Inc. ("RCI Hospitality Holdings, Inc." or the "Company") (NASDAQ: RICK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of RCI Hospitality Holdings, Inc. investors who were adversely affected by alleged securities fraud between December 15, 2021 and September 16, 2025. Follow the link below to get more infor ...

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Lantheus Holdings, Inc. ("Lantheus" or the "Company") (NASDAQ: LNTH) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Lantheus investors who were adversely affected by alleged securities fraud between February 26, 2025 and August 5, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/lantheus-holdings ...

集体诉讼案件概述 - 律师事务所Levi & Korsinsky, LLP通知WPP plc投资者有关证券集体诉讼事宜，该诉讼旨在为在2025年2月27日至2025年7月8日期间因涉嫌证券欺诈而遭受损失的投资者挽回损失 [1] 指控核心内容 - 指控称，被告向投资者提供了过于积极的陈述，但同时散布了 materially false and misleading statements 和/或隐瞒了重大不利事实，涉及WPP媒体部门的真实状况 [2] - 被隐瞒的事实包括WPP媒体部门并未真正准备好应对持续的宏观经济挑战并在竞争中保持有效，且已开始将 significant market share 输给竞争对手 [2] 业绩披露与市场反应 - 2025年7月9日，WPP发布2025年上半年交易更新，告知投资者其业绩在第二季度出现恶化 [2] - 公司将业绩不佳归因于持续的宏观不确定性对客户支出的影响、弱于预期的净新业务，以及WPP Media（即GroupM）持续重组对业务造成的一些干扰 [2] - 此消息公布后，WPP普通股股价从2025年7月8日的收盘价每股35.82美元，下跌至2025年7月9日的每股29.34美元，单日跌幅约18.1% [2] 律师事务所信息 - Levi & Korsinsky律师事务所在过去20年间为受损股东追回数亿美元，并在高风险案件中拥有胜诉记录 [4] - 该事务所在代表投资者处理复杂证券诉讼方面拥有广泛专业知识，团队拥有超过70名员工 [4] - 连续七年被ISS Securities Class Action Services评为美国顶级证券诉讼律师事务所之一 [4]

NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Savara Inc. ("Savara Inc." or the "Company") (NASDAQ: SVRA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Savara Inc. investors who were adversely affected by alleged securities fraud between March 4, 2024 and May 23, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/savara-inc-lawsuit-submission ...

NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cytokinetics, Incorporated (NASDAQ: CYTK). Shareholders who purchased shares of CYTK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/cytokinetics-incorporated-loss-submission-form/?id=173217&from=3 CLASS ...